Abstract
Congenital heart disease can lead to various lymphatic complications including traumatic leaks, lymphatic overproduction, conduction abnormalities or lymphedema. Advancements in the imaging of central lymphatics and guided interventions have improved outcomes in these children. Dynamic contrast-enhanced magnetic resonance (MR) lymphangiography allows for the assessment of abnormal lymphatic drainage. This technique is preferred for evaluating lymphatic conditions such as plastic bronchitis, chylothorax, chyloptysis, chylopericardium, protein-losing enteropathy and chylous ascites, among other lymphatic disorders. In this review, we discuss lymphatic abnormalities encountered on MRI in children with congenital heart disease. We also briefly review treatment options.
Similar content being viewed by others
References
Kelly B, Mohanakumar S, Hjortdal VE (2020) Diagnosis and management of lymphatic disorders in congenital heart disease. Curr Cardiol Rep 22:164
Rapp JB, White AM, Otero HJ, Biko DM (2021) Computed tomography of the airways and lungs in congenital heart disease. Pediatr Radiol. https://doi.org/10.1007/s00247-021-05186-6
Itkin M, Chidekel A, Ryan KA, Rabinowitz D (2020) Abnormal pulmonary lymphatic flow in patients with paediatric pulmonary lymphatic disorders: diagnosis and treatment. Paediatr Respir Rev 36:15–24
Dori Y, Keller MS, Rychik J, Itkin M (2014) Successful treatment of plastic bronchitis by selective lymphatic embolization in a Fontan patient. Pediatrics 134:e590–595
Ramirez-Suarez KI, Tierradentro-Garcia LO, Smith CL et al (2021) Dynamic contrast-enhanced magnetic resonance lymphangiography. Pediatr Radiol 52:285–294
Butler MG, Isogai S, Weinstein BM (2009) Lymphatic development. Birth Defects Res C Embryo Today 87:222–231
Tomasulo CE, Chen JM, Smith CL et al (2020) Lymphatic disorders and management in patients with congenital heart disease. Ann Thorac Surg 113:1101–1111
Shaikh R, Biko DM, Lee EY (2019) MR imaging evaluation of pediatric lymphatics: overview of techniques and imaging findings. Magn Reson Imaging Clin N Am 27:373–385
Johnson OW, Chick JFB, Chauhan NR et al (2016) The thoracic duct: clinical importance, anatomic variation, imaging, and embolization. Eur Radiol 26:2482–2493
Biko DM, Johnstone JA, Dori Y et al (2018) Recognition of neonatal lymphatic flow disorder: fetal MR findings and postnatal MR lymphangiogram correlation. Acad Radiol 25:1446–1450
Biko DM, Reisen B, Otero HJ et al (2019) Imaging of central lymphatic abnormalities in Noonan syndrome. Pediatr Radiol 49:586–592
Lam CZ, Bhamare TA, Gazzaz T et al (2017) Diagnosis of secondary pulmonary lymphangiectasia in congenital heart disease: a novel role for chest ultrasound and prognostic implications. Pediatr Radiol 47:1441–1451
Bellini C, Boccardo F, Campisi C, Bonioli E (2006) Congenital pulmonary lymphangiectasia. Orphanet J Rare Dis 1:43
Seed M, Bradley T, Bourgeois J et al (2009) Antenatal MR imaging of pulmonary lymphangiectasia secondary to hypoplastic left heart syndrome. Pediatr Radiol 39:747–749
Barrera CA, Johnson AM, Rychik J et al (2021) Prognostic value of the nutmeg lung pattern/lymphangiectasia on fetal magnetic resonance imaging. Pediatr Radiol 51:1809–1817
Victoria T, Andronikou S (2014) The fetal MR appearance of “nutmeg lung”: findings in 8 cases linked to pulmonary lymphangiectasia. Pediatr Radiol 44:1237–1242
Itkin M, Rabinowitz DA, Nadolski G et al (2020) Abnormal pulmonary lymphatic flow in patients with lymphatic anomalies and respiratory compromise. Chest 158:681–691
Barrera CA, Victoria T, Escobar FA et al (2020) Imaging of fetal lymphangiectasias: prenatal and postnatal imaging findings. Pediatr Radiol 50:1872–1880
Chavhan GB, Amaral JG, Temple M, Itkin M (2017) MR lymphangiography in children: technique and potential applications. Radiographics 37:1775–1790
Pinto E, Dori Y, Smith C et al (2021) Neonatal lymphatic flow disorders: impact of lymphatic imaging and interventions on outcomes. J Perinatol 41:494–501
Savla JJ, Itkin M, Rossano JW, Dori Y (2017) Post-operative chylothorax in patients with congenital heart disease. J Am Coll Cardiol 69:2410–2422
Ahmed MA (2021) Post-operative chylothorax in children undergoing congenital heart surgery. Cureus 13:e13811
Mery CM, Moffett BS, Khan MS et al (2014) Incidence and treatment of chylothorax after cardiac surgery in children: analysis of a large multi-institution database. J Thorac Cardiovasc Surg 147:678–686e1
Fredenburg TB, Johnson TR, Cohen MD (2011) The Fontan procedure: anatomy, complications, and manifestations of failure. Radiographics 31:453–463
Khanna G, Bhalla S, Krishnamurthy R, Canter C (2012) Extracardiac complications of the Fontan circuit. Pediatr Radiol 42:233–241
Ghosh RM, Griffis HM, Glatz AC et al (2020) Prevalence and cause of early Fontan complications: does the lymphatic circulation play a role? J Am Heart Assoc 9:e015318
Dori Y, Keller MS, Fogel MA et al (2014) MRI of lymphatic abnormalities after functional single-ventricle palliation surgery. AJR Am J Roentgenol 203:426–431
Menon S, Chennapragada M, Ugaki S et al (2017) The lymphatic circulation in adaptations to the Fontan circulation. Pediatr Cardiol 38:886–892
Witte MH, Dumont AE, Clauss RH et al (1969) Lymph circulation in congestive heart failure: effect of external thoracic duct drainage. Circulation 39:723–733
Milonakis M, Chatzis AC, Giannopoulos NM et al (2009) Etiology and management of chylothorax following pediatric heart surgery. J Card Surg 24:369–373
Schumacher KR, Stringer KA, Donohue JE et al (2015) Fontan-associated protein-losing enteropathy and plastic bronchitis. J Pediatr 166:970–977
Talwar S, Agarwala S, Mittal CM et al (2010) Pleural effusions in children undergoing cardiac surgery. Ann Pediatr Cardiol 3:58–64
Kim G, Ko H, Byun J-H et al (2019) Risk factors for prolonged pleural effusion after extracardiac Fontan operation. Pediatr Cardiol 40:1545–1552
Itkin M, Piccoli DA, Nadolski G et al (2017) Protein-losing enteropathy in patients with congenital heart disease. J Am Coll Cardiol 69:2929–2937
Lemley BA, Biko DM, Dewitt AG et al (2021) Intrahepatic dynamic contrast-enhanced magnetic resonance lymphangiography: potential imaging signature for protein-losing enteropathy in congenital heart disease. J Am Heart Assoc 10:e021542
Sagray E, Johnson JN, Schumacher KR et al (2022) Protein-losing enteropathy recurrence after pediatric heart transplantation: multicenter case series. Pediatr Transplant 2022:e14295
Biko DM, Dori Y, Savoca M et al (2020) Pediatric pulmonary lymphatic flow disorders: diagnosis and management. Paediatr Respir Rev 36:2–7
Ramirez-Suarez KI, Otero HJ, Biko DM et al (2022) Magnetic resonance lymphangiography in post-Fontan palliation patients with MR non-conditional cardiac electronic devices: an institutional experience. Clin Imaging 86:43–52
Dori Y, Smith CL, DeWitt AG et al (2020) Intramesenteric dynamic contrast pediatric MR lymphangiography: initial experience and comparison with intranodal and intrahepatic MR lymphangiography. Eur Radiol 30:5777–5784
Biko DM, Smith CL, Otero HJ et al (2019) Intrahepatic dynamic contrast MR lymphangiography: initial experience with a new technique for the assessment of liver lymphatics. Eur Radiol 29:5190–5196
Nadolski GJ, Ponce-Dorrego MD, Darge K et al (2018) Validation of the position of injection needles with contrast-enhanced ultrasound for dynamic contract-enhanced MR lymphangiography. J Vasc Interv Radiol 29:1028–1030
Dori Y (2016) Novel lymphatic imaging techniques. Tech Vasc Interv Radiol 19:255–261
Dori Y, Keller MS, Rome JJ et al (2016) Percutaneous lymphatic embolization of abnormal pulmonary lymphatic flow as treatment of plastic bronchitis in patients with congenital heart disease. Circulation 133:1160–1170
Mon RA, Treadwell MC, Berman DR et al (2018) Outcomes of fetuses with primary hydrothorax that undergo prenatal intervention (prenatal intervention for hydrothorax). J Surg Res 221:121–127
Carr BD, Sampang L, Church JT et al (2018) Fetal intervention for congenital chylothorax is associated with improved outcomes in early life. J Surg Res 231:361–365
Desai AP, Guvenc BH, Carachi R (2009) Evidence for medium chain triglycerides in the treatment of primary intestinal lymphangiectasia. Eur J Pediatr Surg 19:241–245
Panthongviriyakul C, Bines JE (2008) Post-operative chylothorax in children: an evidence-based management algorithm. J Paediatr Child Health 44:716–721
Brooks K, Caruthers RL, Schumacher KR, Stringer KA (2013) Pharmacotherapy challenges of Fontan-associated plastic bronchitis: a rare pediatric disease. Pharmacotherapy 33:922–934
Heath L, Ling S, Racz J et al (2011) Prospective, longitudinal study of plastic bronchitis cast pathology and responsiveness to tissue plasminogen activator. Pediatr Cardiol 32:1182–1189
Avitabile CM, Goldberg DJ, Dodds K et al (2014) A multifaceted approach to the management of plastic bronchitis after cavopulmonary palliation. Ann Thorac Surg 98:634–640
Li D, March ME, Gutierrez-Uzquiza A et al (2019) ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor. Nat Med 25:1116–1122
Ozeki M, Hori T, Kanda K et al (2016) Everolimus for primary intestinal lymphangiectasia with protein-losing enteropathy. Pediatrics 137:e20152562
Kuroiwa G, Takayama T, Sato Y et al (2001) Primary intestinal lymphangiectasia successfully treated with octreotide. J Gastroenterol 36:129–132
Gray M, Kovatis KZ, Stuart T et al (2014) Treatment of congenital pulmonary lymphangiectasia using ethiodized oil lymphangiography. J Perinatol 34:720–722
Hraška V (2013) Decompression of thoracic duct: new approach for the treatment of failing Fontan. Ann Thorac Surg 96:709–711
Smith CL, Hoffman TM, Dori Y, Rome JJ (2020) Decompression of the thoracic duct: a novel transcatheter approach. Catheter Cardiovasc Interv 95:E56–E61
Attar MA, Donn SM (2017) Congenital chylothorax. Semin Fetal Neonatal Med 22:234–239
Engum SA, Rescorla FJ, West KW et al (1999) The use of pleuroperitoneal shunts in the management of persistent chylothorax in infants. J Pediatr Surg 34:286–290
Kogon B, McConnell M, Book W (2016) Fontan conversion with hepatic vein exclusion: a means for hepatic preservation in single ventricle heart disease. Cardiol Young 26:582–585
Hayashida K, Yamakawa S, Shirakami E (2019) Lymphovenous anastomosis for the treatment of persistent congenital chylothorax in a low-birth-weight infant. Medicine 98:e17575
Weissler JM, Cho EH, Koltz PF et al (2018) Lymphovenous anastomosis for the treatment of chylothorax in infants: a novel microsurgical approach to a devastating problem. Plast Reconstr Surg 141:1502–1507
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
(MP4 7.05 MB)
(MP4 4.60 MB)
Rights and permissions
About this article
Cite this article
Ramirez-Suarez, K.I., Tierradentro-García, L.O., Biko, D.M. et al. Lymphatic anomalies in congenital heart disease. Pediatr Radiol 52, 1862–1876 (2022). https://doi.org/10.1007/s00247-022-05449-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-022-05449-w